Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Randomized Trial of Sedative Choice for Intubation
NCT05277896Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in acute respiratory failure (ARF) comparing Ketamine Group with Etomidate Group (2 arms). Primary endpoint: All-cause, 28-day, In-hospital Mortality. Started Apr 2022; status: completed.
02
Drugs
ketamineetomidate
03
Conditions
acute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT05277896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05277896.